WHAT IS ALREADY KNOWN ABOUT THIS SUBJECTcenter dot More and more countries accept patient reporting in their spontaneous reporting systems.center dot Media exposure about drugs can influence patients and health professionals.center dot Evaluation of patient reporting of adverse drug reactions is needed to provide further evidence of its benefits.WHAT THIS STUDY ADDScenter dot Patient reporting compared with reporting by health professionals after media attention about statins.center dot Patient reports provide additional insight into impact on daily life, the patient-health professional relationship and general worries next to health professionals' reports.To compare adverse drug reaction (ADR) reports from patients and health professionals...
Background: Changes in the European pharmacovigilance legislation make it possible for patients of a...
Introduction Clinical information is needed to assess the causal relationship between a drug and an ...
PURPOSE: This study aims to explore the differences in reported information between adverse drug rea...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECTcenter dot More and more countries accept patient reporting ...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT center dot More and more countries accept patient reporting...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
Patient reporting of adverse drug reactions (ADRs) has become an important element of pharmacovigila...
Background: There has been discussion about the acceptance of adverse drug reactions (ADRs) reported...
Background: There has been discussion about the acceptance of adverse drug reactions (ADRs) reported...
Abstract: Background: There has been discussion about the acceptance of adverse drug reactions (ADRs...
Background: Changes in the European pharmacovigilance legislation make it possible for patients of a...
Background: Changes in the European pharmacovigilance legislation make it possible for patients of a...
Background: Changes in the European pharmacovigilance legislation make it possible for patients of a...
Introduction Clinical information is needed to assess the causal relationship between a drug and an ...
PURPOSE: This study aims to explore the differences in reported information between adverse drug rea...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECTcenter dot More and more countries accept patient reporting ...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT center dot More and more countries accept patient reporting...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
Patient reporting of adverse drug reactions (ADRs) has become an important element of pharmacovigila...
Background: There has been discussion about the acceptance of adverse drug reactions (ADRs) reported...
Background: There has been discussion about the acceptance of adverse drug reactions (ADRs) reported...
Abstract: Background: There has been discussion about the acceptance of adverse drug reactions (ADRs...
Background: Changes in the European pharmacovigilance legislation make it possible for patients of a...
Background: Changes in the European pharmacovigilance legislation make it possible for patients of a...
Background: Changes in the European pharmacovigilance legislation make it possible for patients of a...
Introduction Clinical information is needed to assess the causal relationship between a drug and an ...
PURPOSE: This study aims to explore the differences in reported information between adverse drug rea...